Oxitan 50mg Injection
Marketer
Fresenius Kabi India Pvt Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Oxitan 50mg Injection
Colorectal cancer is treated with the injectable medication, Onxal 50mg. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your individual needs and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, potentially taking weeks or months; discontinue only under medical guidance. Common side effects include nausea, tiredness, vomiting, and diarrhea. A reduction in blood cell counts (red and white) increasing infection risk is possible. Serious allergic responses, signaled by symptoms like mouth sores, rash, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests are crucial to monitor blood cell levels, as well as heart, liver, and uric acid levels. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all current medications, especially those combating infections; drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Male infertility is a potential side effect, necessitating consultation with a physician regarding sperm preservation. Driving is discouraged due to potential dizziness.
Uses of Oxitan 50mg Injection
Colorectal cancer
Major Benefits of Oxitan 50mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Oxitan 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Oxitan 50mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Oxitan 50mg Injection works:
The injectable drug Oxitan 50mg is an antineoplastic agent. Its mechanism of action involves disrupting the DNA and RNA of cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oxitan 50mg Injection may pose unknown safety risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Oxitan 50mg Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Oxitan 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The administration of Oxitan 50mg Injection, and similarly Oxaliplatin treatment, can induce adverse reactions. These may include dizziness, nausea, vomiting, and other neurological effects impacting ambulation, potentially impairing driving ability.
KidneyCAUTION
For individuals with severely impaired kidney function, Oxitan 50mg Injection requires careful administration and potential dose modification. Advice from a physician is necessary. Data regarding Oxitan 50mg Injection use in such patients is limited. No dosage changes are advised for those with mildly or moderately impaired kidney function.
LiverCAUTION
For individuals with hepatic impairment, administering Oxitan 50mg Injection requires careful consideration. Dosage modification of Oxitan 50mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Oxitan 50mg Injection :
Omit doses of Oxitan 50mg Injection only after seeking your physician's advice.
Facts to Know About Oxitan 50mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | Platinum-based anticancer agents |
3,018 People bought this recently